Cargando…
Chronic obstructive pulmonary disease: towards pharmacogenetics
Chronic obstructive pulmonary disease (COPD) is a common problem worldwide, and it is recognized that the term encompasses overlapping sub-phenotypes of disease. The development of a sub-phenotype may be determined in part by an individual's genetics, which in turn may determine response to tre...
Autores principales: | Wood, Alice M, Tan, See Ling, Stockley, Robert A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808747/ https://www.ncbi.nlm.nih.gov/pubmed/19951401 http://dx.doi.org/10.1186/gm112 |
Ejemplares similares
-
The genetics of chronic obstructive pulmonary disease
por: Wood, Alice M, et al.
Publicado: (2006) -
Biomarkers in chronic obstructive pulmonary disease: confusing or useful?
por: Stockley, Robert A
Publicado: (2014) -
Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases
por: Crisford, Helena, et al.
Publicado: (2018) -
An overview of exacerbations of chronic obstructive pulmonary disease: Can tests of small airways' function guide diagnosis and management?
por: Alobaidi, Nowaf Y., et al.
Publicado: (2020) -
Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype?
por: Sevenoaks, Martin J, et al.
Publicado: (2006)